181 related articles for article (PubMed ID: 32554061)
1. Phytonanomedicine: a novel avenue to treat recurrent cancer by targeting cancer stem cells.
Mohapatra P; Singh P; Sahoo SK
Drug Discov Today; 2020 Aug; 25(8):1307-1321. PubMed ID: 32554061
[TBL] [Abstract][Full Text] [Related]
2. Targeting cancer stem cells and signaling pathways by phytochemicals: Novel approach for breast cancer therapy.
Dandawate PR; Subramaniam D; Jensen RA; Anant S
Semin Cancer Biol; 2016 Oct; 40-41():192-208. PubMed ID: 27609747
[TBL] [Abstract][Full Text] [Related]
3. Therapeutic Effectiveness of Anticancer Phytochemicals on Cancer Stem Cells.
Oh J; Hlatky L; Jeong YS; Kim D
Toxins (Basel); 2016 Jun; 8(7):. PubMed ID: 27376325
[TBL] [Abstract][Full Text] [Related]
4. Phytochemical-Based Nanomedicine for Targeting Tumor Microenvironment and Inhibiting Cancer Chemoresistance: Recent Advances and Pharmacological Insights.
Sa P; Mohapatra P; Swain SS; Khuntia A; Sahoo SK
Mol Pharm; 2023 Nov; 20(11):5254-5277. PubMed ID: 37596986
[TBL] [Abstract][Full Text] [Related]
5. Can nanomedicines kill cancer stem cells?
Zhao Y; Alakhova DY; Kabanov AV
Adv Drug Deliv Rev; 2013 Nov; 65(13-14):1763-83. PubMed ID: 24120657
[TBL] [Abstract][Full Text] [Related]
6. Nanomedicine-mediated cancer stem cell therapy.
Shen S; Xia JX; Wang J
Biomaterials; 2016 Jan; 74():1-18. PubMed ID: 26433488
[TBL] [Abstract][Full Text] [Related]
7. Dietary Phytochemicals as a Potential Source for Targeting Cancer Stem Cells.
Manogaran P; Umapathy D; Karthikeyan M; Venkatachalam K; Singaravelu A
Cancer Invest; 2021 Apr; 39(4):349-368. PubMed ID: 33688788
[TBL] [Abstract][Full Text] [Related]
8. Piperlongumine based nanomedicine impairs glycolytic metabolism in triple negative breast cancer stem cells through modulation of GAPDH & FBP1.
Singh P; Sen K; Sa P; Khuntia A; Raghav SK; Swain RK; Sahoo SK
Phytomedicine; 2024 Jan; 123():155181. PubMed ID: 38091824
[TBL] [Abstract][Full Text] [Related]
9. Cancer stem cells and drug resistance: the potential of nanomedicine.
Vinogradov S; Wei X
Nanomedicine (Lond); 2012 Apr; 7(4):597-615. PubMed ID: 22471722
[TBL] [Abstract][Full Text] [Related]
10. Regulatory Role of Quiescence in the Biological Function of Cancer Stem Cells.
Lee SH; Reed-Newman T; Anant S; Ramasamy TS
Stem Cell Rev Rep; 2020 Dec; 16(6):1185-1207. PubMed ID: 32894403
[TBL] [Abstract][Full Text] [Related]
11. A nano-based thermotherapy for cancer stem cell-targeted therapy.
Suo X; Zhang J; Zhang Y; Liang XJ; Zhang J; Liu D
J Mater Chem B; 2020 May; 8(18):3985-4001. PubMed ID: 32239013
[TBL] [Abstract][Full Text] [Related]
12. Colon carcinogenesis: influence of Western diet-induced obesity and targeting stem cells using dietary bioactive compounds.
Kasdagly M; Radhakrishnan S; Reddivari L; Veeramachaneni DN; Vanamala J
Nutrition; 2014; 30(11-12):1242-56. PubMed ID: 25280404
[TBL] [Abstract][Full Text] [Related]
13. Eradicating the tumor "seeds": nanomedicines-based therapies against cancer stem cells.
Li L; Ni R; Zheng D; Chen L
Daru; 2023 Jun; 31(1):83-94. PubMed ID: 36971921
[TBL] [Abstract][Full Text] [Related]
14. Targeting vasculogenic mimicry by phytochemicals: A potential opportunity for cancer therapy.
Haiaty S; Rashidi MR; Akbarzadeh M; Maroufi NF; Yousefi B; Nouri M
IUBMB Life; 2020 May; 72(5):825-841. PubMed ID: 32026601
[TBL] [Abstract][Full Text] [Related]
15. Cancer stem cells in drug resistant lung cancer: Targeting cell surface markers and signaling pathways.
Leon G; MacDonagh L; Finn SP; Cuffe S; Barr MP
Pharmacol Ther; 2016 Feb; 158():71-90. PubMed ID: 26706243
[TBL] [Abstract][Full Text] [Related]
16. Cancer Stem Cells and their Management in Cancer Therapy.
Shenouda S; Kulkarni K; Abuetabh Y; Sergi C
Recent Pat Anticancer Drug Discov; 2020; 15(3):212-227. PubMed ID: 32660407
[TBL] [Abstract][Full Text] [Related]
17. Dietary Phytochemicals Targeting Cancer Stem Cells.
Liskova A; Kubatka P; Samec M; Zubor P; Mlyncek M; Bielik T; Samuel SM; Zulli A; Kwon TK; Büsselberg D
Molecules; 2019 Mar; 24(5):. PubMed ID: 30836718
[TBL] [Abstract][Full Text] [Related]
18. EMT, CTCs and CSCs in tumor relapse and drug-resistance.
Mitra A; Mishra L; Li S
Oncotarget; 2015 May; 6(13):10697-711. PubMed ID: 25986923
[TBL] [Abstract][Full Text] [Related]
19. Delivery of therapeutics using nanocarriers for targeting cancer cells and cancer stem cells.
Krishnamurthy S; Ke X; Yang YY
Nanomedicine (Lond); 2015 Jan; 10(1):143-60. PubMed ID: 25597774
[TBL] [Abstract][Full Text] [Related]
20. Targeting cancer stem cells with dietary phytochemical - Repositioned drug combinations.
Chan MM; Chen R; Fong D
Cancer Lett; 2018 Oct; 433():53-64. PubMed ID: 29960048
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
